http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 09 Sep 2026 07:32:41 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Galmed+Pharma+rebrands+as+Eocene%2C+changes+ticker+to+EOCN/27039329.html <p>Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announced a corporate rebranding to Eocene Ltd., along with a trading symbol change on the Nasdaq Capital Market to "EOCN," effective September 10, 2026.</p><p>The company said the new name, derived from ancient Greek words meaning "dawn" and "new," reflects its shift from a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology diseases to a gastrointestinal-focused medtech and biopharmaceutical platform.</p><p>The rebranding follows the company's acquisition of Colospan Ltd., a commercial-stage medical device company that has developed a solution targeting anastomotic leak complications following colorectal surgery. Colospan's device, CG-100, is described as commercially available in Europe http://www.streetinsider.com/Corporate+News/Galmed+Pharma+rebrands+as+Eocene%2C+changes+ticker+to+EOCN/27039329.html Wed, 09 Sep 2026 07:32:41 -0400 EOCN GLMD http://www.streetinsider.com/Corporate+News/Galmed+Pharma+rebrands+as+Eocene%2C+changes+ticker+to+EOCN/27039329.html <p>Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announced a corporate rebranding to Eocene Ltd., along with a trading symbol change on the Nasdaq Capital Market to "EOCN," effective September 10, 2026.</p><p>The company said the new name, derived from ancient Greek words meaning "dawn" and "new," reflects its shift from a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology diseases to a gastrointestinal-focused medtech and biopharmaceutical platform.</p><p>The rebranding follows the company's acquisition of Colospan Ltd., a commercial-stage medical device company that has developed a solution targeting anastomotic leak complications following colorectal surgery. Colospan's device, CG-100, is described as commercially available in Europe http://www.streetinsider.com/Corporate+News/Galmed+Pharma+rebrands+as+Eocene%2C+changes+ticker+to+EOCN/27039329.html Wed, 09 Sep 2026 07:32:41 -0400 EOCN GLMD